Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reiss

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|March 14, 2000
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyM H Reijers, H M Weigel, A A Hart, et al.
Biological Psychiatry|November 14, 2006
Striatal function in generalized social phobia: a functional magnetic resonance imaging studyJitender Sareen, Darren W Campbell, William D Leslie, et al.
Annals of Internal Medicine|August 19, 2014
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort studyY Joseph Hwang, Stephanie N Dixon, Jeffrey P Reiss, et al.
HIV Medicine|July 29, 2015
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D studyA C Achhra, A Mocroft, P Reiss, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Nevirapine plus didanosine: once or twice daily combination?R P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Journal of Clinical Microbiology|February 3, 2000
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patientsB S Blank, P L Meenhorst, J W Mulder, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|March 14, 2000
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM studyM H Reijers, H M Weigel, A A Hart, et al.
Biological Psychiatry|November 14, 2006
Striatal function in generalized social phobia: a functional magnetic resonance imaging studyJitender Sareen, Darren W Campbell, William D Leslie, et al.
Annals of Internal Medicine|August 19, 2014
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort studyY Joseph Hwang, Stephanie N Dixon, Jeffrey P Reiss, et al.
HIV Medicine|July 29, 2015
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D studyA C Achhra, A Mocroft, P Reiss, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Nevirapine plus didanosine: once or twice daily combination?R P van Heeswijk, A I Veldkamp, J W Mulder, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Journal of Clinical Microbiology|February 3, 2000
Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patientsB S Blank, P L Meenhorst, J W Mulder, et al.
AIDS (London, England)|December 12, 2001
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profileM van der Valk, J J Kastelein, R L Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 9, 1997
Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study GroupJ D Lundgren, A N Phillips, S Vella, et al.
Pageof 21